Trump plans generic drug tariffs from 2028 with two-year delay testing U.S. onshoring push

Per CNBC, President Trump plans to implement tariffs on generic drugs beginning in twenty twenty-eight, aimed at reshoring low-cost drug production to the United States. The plan targets India—a major supplier of generic drugs—but displacing an established supply chain won't be easy.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton